FDA — authorised 15 June 1949
- Status: approved
🇺🇸 Paradione in United States
FDA authorised Paradione on 15 June 1949
Marketing authorisations
FDA — authorised 15 June 1949
- Application: NDA006800
- Marketing authorisation holder: ABBVIE
- Local brand name: PARADIONE
- Indication: CAPSULE — ORAL
- Status: approved
Paradione in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Paradione approved in United States?
Yes. FDA authorised it on 15 June 1949; FDA authorised it on 15 June 1949.
Who is the marketing authorisation holder for Paradione in United States?
Marketing authorisation holder not available in our data.